JAMP EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE

Identification of Jamp Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate

No description

Google image searchProduct monograph

Active ingredients

efavirenz, 600 MG

emtricitabine, 200 MG

tenofovir disoproxil fumarate, 300 MG

DIN: 02519461

Dosage form(s): TABLET

Route(s) of administration: ORAL

Schedule: Prescription

Company: JAMP PHARMA CORPORATION

Date: 14-DEC-2022

ATC:

• J05 — ANTIVIRALS FOR SYSTEMIC USE (ATC, ATC/DDD, )
• J05A — DIRECT ACTING ANTIVIRALS (ATC, ATC/DDD)
• J05AR — Antivirals for treatment of HIV infections, combinations (ATC, ATC/DDD)
• J05AR06 — EMTRICITABINE, TENOFOVIR DISOPROXIL AND EFAVIRENZ (ATC/DDD)

Reference brand drug: Atripla

Pharmaceutical standard: MFR

External Links for Jamp Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate

Search on Google

• Jamp Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate side effects
• Jamp Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate dosage
• efavirenz side effects
• efavirenz dosage
• emtricitabine side effects
• emtricitabine dosage
• tenofovir disoproxil fumarate side effects
• tenofovir disoproxil fumarate dosage